DLB

DOLBY LABORATORIES, INC.

DLB · CIK 1308547 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$1.3B
20182025
Net Income$0.3B
20182025
Operating CF$0.5B
20182025
Free Cash Flow$0.4B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$1.3B$1.3B$1.3B$1.3B$1.3B$0.3B$1.2B$0.3B
Cost of Revenue$0.2B$0.1B$0.2B$0.1B$0.1B$0.0B$0.0B$0.0B
Gross Profit$1.2B$1.1B$1.1B$1.1B$1.2B$0.2B$0.3B$0.2B
R&D Expense$0.3B$0.3B$0.3B$0.3B$0.3B$0.2B$0.2B$0.2B
SG&A Expense————————
Operating Income$0.3B$0.3B$0.2B$0.2B$0.3B$0.2B$0.3B$0.3B
Net Income$0.3B$0.3B$0.2B$0.2B$0.3B$0.0B$0.0B$0.1B
EPS (Basic)$2.66$2.74$2.10$1.84$3.07$0.27$0.44$0.48
EPS (Diluted)$2.62$2.69$2.05$1.81$2.97$0.26$0.43$0.47

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$3.2B$3.1B$3.0B$2.7B$3.1B$2.9B$2.8B$2.7B
Current Assets$1.4B$1.2B$1.5B$1.3B$1.8B$1.5B$1.4B$1.3B
Cash & Equivalents$0.7B$0.5B$0.7B$0.6B$1.2B$1.1B$0.8B$0.9B
Total Liabilities$0.6B$0.6B$0.6B$0.4B$0.5B$0.5B$0.5B$0.5B
Current Liabilities$0.4B$0.4B$0.4B$0.3B$0.3B$0.3B$0.3B$0.3B
Stockholders' Equity$2.6B$2.5B$2.4B$2.2B$2.6B$2.4B$2.3B$2.2B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.5B$0.3B$0.4B$0.3B$0.4B$0.3B$0.3B$0.4B
Investing Cash Flow$-0.0B$-0.3B$0.1B$-0.3B$-0.0B$0.1B$-0.1B$0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.1B$0.1B$0.1B$0.1B
Financing Cash Flow$-0.2B$-0.3B$-0.2B$-0.6B$-0.3B$-0.2B$-0.4B$-0.1B
← Companies